drugset
drugset / Trial / NCT05528172

A Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Cataract Surgery

NCT05528172 ↗

Phase 3 Completed 331 enrolled Kowa Research Institute, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the safety and efficacy of K-321 in subjects after cataract surgery

Timeline

Start
2022-08-04
Primary completion
2023-06-22
Completion
2023-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Ripasudil Small molecule — Other

Indications

corneal edema